JULIAN
CARRETERO ASUNCION
TITULAR DE UNIVERSIDAD
University of Texas MD Anderson Cancer Center
Houston, Estados UnidosPublications en collaboration avec des chercheurs de University of Texas MD Anderson Cancer Center (3)
2018
-
De novo lipogenesis represents a therapeutic target in mutant Kras non-small cell lung cancer
FASEB Journal, Vol. 32, Núm. 12, pp. 7018-7027
2013
-
Metabolic and functional genomic studies identify deoxythymidylate kinase as a target in LKB1 -mutant lung cancer
Cancer Discovery, Vol. 3, Núm. 8, pp. 870-879
2009
-
HIF2α cooperates with RAS to promote lung tumorigenesis in mice
Journal of Clinical Investigation, Vol. 119, Núm. 8, pp. 2160-2170